NanoViricides, Inc.

Investors’ Short Memories The events that followed 11 September 2001 brought to companies like Human Genome Sciences, Inc. and Acambis PLC (subsequently acquired by GSK plc and Sanofi , re

Bristol-Myers Squibb Co. ’s chief commercial officer, Murdo Gordon , has left the company to “pursue another opportunity” in the same week as the company’s Q2 results are published. A replacement i

The renewed break-out of a frighteningly deadly virus with no known cure or vaccine in a region that will shortly host a couple of million international pilgrims has prompted a rash of recent headline

AbbVie became the latest firm to test the FDA "voucher" strategy as a pathway to success – entering into a $350m deal with United Therapeutics in an effort to get an experimental medicine to the marke